RYAN ARTHUR F Insider Trading -- Recent SEC Form 4 Transactions

RYAN ARTHUR F (CIK 1187443) reported 49 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-07). Recent activity: Sell REGN (200 shares), Sell REGN (2 shares), Sell REGN (15 shares), Sell REGN (24 shares), Sell REGN (15 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-07-07REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell200$130,030
2026-05-04REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell2$1,428
2026-05-04REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell15$10,537
2026-05-04REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell24$16,883
2026-05-04REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell15$10,564
2026-05-04REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell14$9,878
2026-05-04REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell7$4,947
2026-05-04REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell4$2,830
2026-05-04REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell6$4,257
2026-05-04REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell2$1,422
2026-05-04REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell5$3,557
2026-05-04REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell1$712
2026-05-04REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell5$3,509
2026-04-03REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell1$771
2026-04-03REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell3$2,318
2026-04-03REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell8$6,189
2026-04-03REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell8$6,197
2026-04-03REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell14$10,858
2026-04-03REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell13$10,096
2026-04-03REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell9$6,997
2026-04-03REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell4$3,113
2026-04-03REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell40$31,188
2026-03-03REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell7$5,442
2026-03-03REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell2$1,557
2026-03-03REGENERON PHARMACEUTICALS, INC. (REGN)DirectorSell5$3,898

Source: SEC Form 4 filings · as of 2026-07-07